Anastacia Wall, PA-C - University of Colorado Denver

Anastacia L. Wall, PA-C
8092 E 49th Pl Denver, CO 80238
[email protected]
(206) 351-3331 cell (303)266-0774 pager
EXPERIENCE
September 2013 – present
Instructor/Physician Assistant
University of Colorado-Denver
Dr. Tim Vollmer, MD
Rocky Mountain Multiple Sclerosis Center
University of Colorado Hospital-- Anschutz Outpatient Pavilion
1635 Aurora Court, Suite 5210
Aurora, CO 80045
Telephone: (720) 848-2080 Fax: (720) 848-0640
February 2012 – August 2013
Neurology Physician Assistant
Swedish Neuroscience Specialists, Swedish Medical Group (SMG)
Dr. Lily Jung Henson, MD
751 NE Blakely Dr, Suite 4020
Issaquah, WA 98029
Office: (425) 313-7070
January 2008 – February 2012
Neurohospitalist Physician Assistant
Swedish Neuroscience Institute (SNI)
Joint Commission Certified Comprehensive Stroke Center, Telestroke Program
Dr. Bill Likosky, MD, Stroke Program Medical Director
Swedish Medical Center (SMC)
500 17th Ave Seattle, WA 98122
Office: (206) 320-2208
January 2000 – July 2005
Director of Clinical Education/Clinical Specialist
Swedish Sleep Medicine Associates
Dr. Ralph Pascualy, Medical Director
801 Broadway, Ste 701 Seattle WA 98122
Office: (206) 386-4744
2001 - 2005
Associate Professor
Highline Community College, Polysomnography Technology Program
Post Office Box 98000
Des Moines, Washington 98198-9800
Office: (206) 592-3677
LICENSURES/CERTIFICATIONS
CITI Program Certification for Clinical Investigators
EDSS Certified
Colorado State License: PA 3785
Washington State License: PA10005372
DEA #MW1730868
NCCPA: Certified Physician Assistant, #1079998
1
Anastacia L. Wall, PA-C
8092 E 49th Pl Denver, CO 80238
[email protected]
(206) 351-3331 cell (303)266-0774 pager
RESEARCH
ONO-4641POU007 (EMR 200559-002): A safety and efficacy extension study of ONO-4641
in patients with relapsing remitting multiple sclerosis
CFTY720D2312: A 12-month, randomized, rater- and dose-blinded study to compare the efficacy
and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate
20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple
sclerosis
CBAF312A2304: A multicenter, randomized, double-blind, parallel-group, placebo-controlled
variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in
patients with secondary progressive multiple sclerosis
LAQ-MS-305: A multinational, multicenter, randomized, double-blind, parallel-group, placebocontrolled study followed by an active treatment period, to evaluate the efficacy, safety and
tolerability of two doses of oral administration of laquinimod (0.6 mg/day or 1.2 mg/day) in
subjects with relapsing remitting multiple sclerosis (RRMS)
MS-LAQ-302E: Study Title: A multinational, multicenter, open-label, single-assignment extension of
the MS-LAQ-302 (BRAVO) study, to evaluate the long-term safety, tolerability and effect on disease
course of daily oral laquinimod 0.6 mg in subjects with relapsing multiple sclerosis
IM22-MS-1004: A Double-Blind, Placebo-Controlled, Single Ascending Intravenous Infusion Study
of rHIgM22 in Patients with Multiple Sclerosis
Gateway II: A Phase II, Double Blinded, Placebo Controlled, Randomized Study Comparing
Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate
Monotherapy in Patients with Relapsing Forms of Multiple Sclerosis
Current sub-investigator in Opexa study Abili-T 2012-00, outsite #004, A novel T-cell
immunotherapy that has been granted Fast Track designation by the U.S. FDA for the Secondary
Progressive MS (SP-MS) indication
Erica Tomas, Anastacia Wall, Amer Malik, and Lily Jung-Henson. IRIS in a Multiple Sclerosis Patient
after Discontinuation of Natalizumab and Newly Started on Fingolimod. (P04.133) Neurology April
22, 2012 78:P04.133
Poster Presentation P04.133 American Academy of Neurology Annual Conference, New Orleans,
April 2012
DEFUSE 2 trial: To predict which patients will benefit from endovascular therapy for acute stroke
using MRI perfusion/diffusion technology. 2011- 2012
DIAS 4 trial: To evaluate the effectiveness of desmoteplase vs. placebo in terms of favorable
outcome at Day 90 in subjects with acute ischemic stroke 2011-2012
2
Anastacia L. Wall, PA-C
8092 E 49th Pl Denver, CO 80238
[email protected]
(206) 351-3331 cell (303)266-0774 pager
EDUCATION
2005 - 2007 Bachelor’s of Clinical Health Service
MEDEX Northwest Physician Assistant Program
University of Washington, School of Medicine
4311 11th Ave NE, Ste 200 Seattle WA 98105
(206) 616-4001
2002 - 2003 Training Specialist Certificate
University of Washington
Seattle WA 98105
(206) 897-8939
1997 – 2000 Bachelor of Arts (Phi Beta Kappa, cum laude)
University of Washington
Box 355850 Seattle WA 98195-5850
(206) 543-2100
PROFESSIONAL MEMBERSHIPS
Consortium of Multiple Sclerosis Centers 2013
American Academy of Neurology 2007-present
Washington State Neurological Society 2009-present
Washington Academy of Physician Assistants, 2005 - Present
American Academy of Physician Assistants, 2005 – Present.
--Student HOD representative 2005-2006
COMMITTEES/PRIVILEGES
Hospital privileges at University of Colorado Hospital Sept 2013-present
Swedish Medical Group, Advanced Practice Clinician Council, Chairperson, April to August 2013
SMG, Physician Executive Committee, Human Resources Committee, April to August 2013
SNI Neurology Advanced Practice Committee, Chairperson February to August 2013
Planning committee for Acute Care Neurology and Neurosurgery conference, June 2012
SNI Advanced Practice Clinician leadership committee 2010-2012
Telestroke Planning committee 2010-2011
Hospital privileges at Swedish Medical Center, 2008-2013
PUBLIC SPEAKING ENGAGEMENTS
American Heart Association Champion
Swedish Medical Center Community Events--Topic: Stroke Prevention
SNI Grand Rounds
SNI Case conference
3
Anastacia L. Wall, PA-C
8092 E 49th Pl Denver, CO 80238
[email protected]
(206) 351-3331 cell (303)266-0774 pager
RECENT PROFESSIONAL VOLUNTEERISM
National Multiple Sclerosis Society Walk MS, Swedish S’myelin Striders, Co-captain, 2013
National Multiple Sclerosis Society Bike MS--Mount Vernon 2011, 2012
National Multiple Sclerosis Society Walk MS--Seattle 2012
National Parkinson Foundation: Hope Through Research, 2012
Hands of Hope, Medical mission to Guatemala April 2007
HONORS AND AWARDS
Richard H Peterson Commitment to Excellence Award 2008
University of Washington, Phi Beta Kappa and departmental honors, 1999
Mary Gates Leadership Endowment, 1998-1999
S. Sterling Munro Public Service Fellowship, 1998-1999
Anastacia Wall, PA-C is on the clinical and research team at Rocky Mountain Multiple Sclerosis Center at the
Anschutz Medical Center. She works in partnership with Dr. Vollmer to provide comprehensive care for their
patients. Anastacia completed her undergraduate and professional training at the University of Washington
MEDEX NW program in Seattle. Her first position was as a Neuro-Hospitalist at Swedish Neuroscience
Institute (SNI); a Comprehensive Stroke Center. She then transitioned to outpatient Neurology, seeing
patients with a focus in Neuro-Immunology. While in Seattle, she pioneered the development of and served as
chairperson for both the Advanced Practice Clinician Executive Council and the SNI Neuroscience Advanced
Practice Clinician Committee. She enjoys heading to the mountains with her husband, two children, and
Chesapeake Bay Retrievers.
4